US Codex
Bill
Notes

STOP Act 2.0

S. 5290 · 117th Congress · Dec 15, 2022 · Lineage

A BILL

To require an evaluation of the implementation of the STOP Act of 2018, and for other purposes.

Section 1 Short title

This Act may be cited as the “STOP Act 2.0”.

Sec. 2 Evaluation of implementation of STOP Act of 2018

Not later than one year after the date of the enactment of this Act, the Comptroller General of the United States shall submit to Congress a report evaluating the implementation of the provisions of and amendments made by the STOP Act of 2018 (subtitle A of title VIII of Public Law 115–271; 132 Stat. 4073) that includes—
(1)
an identification of potential areas of risk with respect to the entry of illicit fentanyl, other synthetic opioids, and other narcotics and psychoactive substances into the United States by mail, including any openings that drug traffickers have found in the system established under the STOP Act of 2018; and
(2)
an assessment of—
(A)
the use of the authority provided under subclause (II) of section 343(a)(3)(K)(vi) of the Trade Act of 2002 (19 U.S.C. 1415(a)(3)(K)(vi)), as amended by section 8003 of the STOP Act of 2018, to exclude countries from the requirement under subclause (I) of that section that advance information be provided for 100 percent of international mail shipments; and
(B)
whether the use of that authority should be decreased.

Sec. 3 Public-private partnership regarding postal data

The Secretary of Homeland Security and the Administrator of the Drug Enforcement Administration may enter into a public-private partnership with private parcel services to develop technology and processes for identifying information that could be used to identify the origin of fentanyl, other synthetic opioids, and other narcotics and psychoactive substances, and precursors to such substances, including information on the origin of parcels and shipping information.

Sec. 4 International collaboration

The Secretary of State, in coordination with the Secretary of Homeland Security and the Administrator of the Drug Enforcement Administration, are authorized to share and receive information, consistent with existing law, on best practices regarding the detection of illicit fentanyl, other synthetic opioids, and other narcotics and psychoactive substances, and precursors to such substances, including such substances moving through the mail.